Calcimimetics inhibit renal pathology in rodent nephronophthisis

Kidney International

Volumn 80, Issue 6, 2011, Pages 612-619

  Chen, Neal X ^a   Moe, Sharon M ^a,b   Eggleston Gulyas, Tracy ^a   Chen, Xianming ^a   Hoffmeyer, William D ^a   Bacallao, Robert L ^a   Herbert, Brittney S ^a   Gattone, Vincent H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

calcium sensing receptor; polycystic kidney disease; renal fibrosis; renal pathology

Indexed keywords

CALCIMIMETIC AGENT; CALCIUM; CALCIUM SENSING RECEPTOR; CYCLIC AMP; NITROGEN; PARATHYROID HORMONE; PHOSPHATE; TECALCET; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; EXTRACELLULAR CALCIUM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY COLLECTING TUBULE; KIDNEY CYST; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; MALE; MOUSE; NEPHRONOPHTHISIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

EID: 80052262928     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.139     Document Type: Article

References (34)

1. Zerres K, Rudnik-Schoneborn S, Steinkamm C et al. Autosomal recessive polycystic kidney disease. J Mol Med 1998; 76: 303-309. (Pubitemid 28168328)
2. Hildebrandt F, Otto E. Molecular genetics of nephronophthisis and medullary cystic kidney disease. J Am Soc Nephrol 2000; 11: 1753-1761.
3. Pazour GJ, San Agustin JT, Follit JA et al. Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr Biol 2002; 12: R378-R380. (Pubitemid 34689219)
4. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009; 76: 149-168.
5. Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol 2010; 5(Suppl 1): S23-S30.
6. Brown EM. Physiology and pathophysiology of the extracellular calciumsensing receptor. Am J Med 1999; 106: 238-253. (Pubitemid 29115966)
7. Gerbino A, Ruder WC, Curci S et al. Termination of cAMP signals by Ca2+ and G(alpha)i via extracellular Ca2+ sensors: a link to intracellular Ca2+ oscillations. J Cell Biol 2005; 171: 303-312. (Pubitemid 41540022)
8. Sands JM, Naruse M, Baum M et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 1997; 99: 1399-1405. (Pubitemid 27142778)
9. Brown EM. Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR). Biochem Pharmacol 2010; 80: 297-307.
10. Gattone II VH, Chen NX, Sinders RM et al. Calcimimetic inhibits late-stage cyst growth in ADPKD. J Am Soc Nephrol 2009; 20: 1527-1532.
11. Riccardi D, Lee WS, Lee K et al. Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 1996; 271(4 Part 2): F951-F956.
12. Gensure RC, Gardella TJ, Juppner H. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 2005; 328: 666-678. (Pubitemid 40208304)
13. Murray TM, Rao LG, Divieti P et al. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 2005; 26: 78-113. (Pubitemid 40209388)
14. Brown EM. The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics. Subcell Biochem 2007; 45: 139-167.
15. Grantham JJ. Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach. Kidney Int 2003; 64: 1157-1162. (Pubitemid 37153779)
16. Yamaguchi T, Wallace DP, Magenheimer BS et al. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 2004; 279: 40419-40430. (Pubitemid 39287631)
17. Gattone II VH, Wang X, Harris PC et al. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 2003; 9: 1323-1326. (Pubitemid 37279858)
18. Qian Q, Hunter LW, Li M et al. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum Mol Genet 2003; 12: 1875-1880. (Pubitemid 36944141)
19. Nagao S, Nishii K, Yoshihara D et al. Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat. Kidney Int 2008; 73: 269-277.
20. Nauli SM, Alenghat FJ, Luo Y et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003; 33: 129-137. (Pubitemid 36177063)
21. Wang S, Zhang J, Nauli SM et al. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol Cell Biol 2007; 27: 3241-3252. (Pubitemid 46581334)
22. Pi M, Chen L, Huang M et al. Parathyroid-specific interaction of the calcium-sensing receptor and G alpha q. Kidney Int 2008; 74: 1548-1556.
23. Tu CL, Chang W, Xie Z et al. Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes. J Biol Chem 2008; 283: 3519-3528.
24. Geibel JP, Hebert SC. The functions and roles of the extracellular Ca2+-sensing receptor along the gastrointestinal tract. Annu Rev Physiol 2009; 71: 205-217.
25. Saidak Z, Mentaverri R, Brown EM. The role of the calcium-sensing receptor in the development and progression of cancer. Endocr Rev 2009; 30: 178-195.
26. Chakravarti B, Dwivedi SK, Mithal A et al. Calcium-sensing receptor in cancer: good cop or bad cop? Endocrine 2009; 35: 271-284.
27. Simons M, Gloy J, Ganner A et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet 2005; 37: 537-543. (Pubitemid 40617284)
28. Lancaster MA, Louie CM, Silhavy JL et al. Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat Med 2009; 15: 1046-1054.
29. Wang X, Harris PC, Somlo S et al. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease. Nephrol Dial Transplant 2009; 24: 526-534.
30. Mason SB, Liang Y, Sinders RM et al. Disease stage characterization of hepatorenal fibrocystic pathology in the PCK rat model of ARPKD. Anat Rec (Hoboken) 2010; 293: 1279-1288.
31. Olbrich H, Fliegauf M, Hoefele J et al. Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat Genet 2003; 34: 455-459. (Pubitemid 36935341)
32. Moe SM, Duan D, Doehle BP et al. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003; 63: 1003-1011. (Pubitemid 36315578)
33. Xu C, Shmukler BE, Nishimura K et al. Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells. Am J Physiol Renal Physiol 2009; 296: F1464-F1476.
34. Chen NX, Kircelli F, O'Neill KD et al. Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int 2010; 77: 436-442.